文献速递心血管CT

心房颤动患者冠状动脉CT血管成像的方案与性能:系统评价与荟萃分析

Protocol and performance of coronary computed tomography angiography in patients with atrial fibrillation: a systematic review and meta-analysis.
PubMed 文献 · Clin Radiol · 2025-11-12

该系统评价与荟萃分析纳入14项研究共601例心房颤动患者,评估碘普罗胺370 mgI/ml增强冠状动脉CT血管成像诊断冠心病的效果。11项研究汇总显示98%的节段可诊断(95%CI 0.96-0.99),每患者ROC为0.97(95%CI 0.95-0.98),每节段ROC为0.99(95%CI 0.98-0.99);前瞻性触发或个体化电压方案使辐射剂量降低约50%。

要点

  • 心房颤动患者行碘普罗胺370 mgI/ml增强CCTA,98%的节段可诊断(95%CI 0.96-0.99)。
  • 每患者诊断冠心病的ROC为0.97(95%CI 0.95-0.98),每节段ROC为0.99(95%CI 0.98-0.99)。
  • ≥128层扫描仪或个体化方案可进一步改善图像质量,前瞻性触发或个体化电压方案降低辐射剂量约50%。

核心结论

  • 荟萃分析显示,碘普罗胺370 mgI/ml增强CCTA在心房颤动患者中提供一致的图像质量并准确诊断冠心病。
  • 使用高性能扫描仪联合个体化方案与前瞻性采集可进一步改善图像质量并降低辐射暴露。

研究设计与样本

  • 系统评价与荟萃分析,检索PubMed、Embase、Web of Science和Cochrane Library从建库至2025年2月。
  • 纳入14项研究共601例心房颤动患者,均接受碘普罗胺370 mgI/ml增强CCTA。
  • 采用随机效应模型汇总诊断节段比例、有效辐射剂量、敏感度、特异度及诊断冠心病的ROC曲线,参考标准为传统血管造影。
  • 多数研究采用个体化对比剂和电压方案。

诊断标准与关键数值

  • 11项研究汇总显示98%的节段可诊断(95%CI 0.96-0.99),在心率变化>50次/分、超重和心脏瓣膜病患者亚组中结果一致。
  • 每患者诊断冠心病的ROC为0.97(95%CI 0.95-0.98),每节段ROC为0.99(95%CI 0.98-0.99)。
  • ≥128层扫描仪或个体化方案可进一步改善图像质量。
  • 前瞻性触发或个体化电压方案使辐射剂量降低约50%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: The aim of this study was to systematically investigate protocols and performance of iopromide contrast-enhanced coronary computed tomography angiography (CCTA) for diagnosing coronary artery disease (CAD) in patients with atrial fibrillation (AF).

MATERIALS AND METHODS: We searched PubMed, Embase, Web of Science, and the Cochrane Library for eligible studies of iopromide contrast-enhanced CCTA in patients with AF from inception to February 2025. Using a random-effect model, we pooled the following diagnostic metrics of CCTAs from included studies: diagnostic segments, effective radiation dose, sensitivity, specificity, and receiver operating characteristic (ROC) curve for CAD diagnosis versus conventional angiography.

RESULTS: We included 14 studies involving 601 patients with AF who underwent iopromide 370 mgI/ml contrast-enhanced CCTA. Most studies applied individualised contrast and voltage protocols. Pooled analysis in 11 of those 14 studies indicated 98% segments were diagnostic (95% confidence interval [CI]: 0.96-0.99) with consistent results in subgroups of patients with heart rate variation >50 beats per minute, patients with overweight status, and patients with heart valve diseases. Scanners with ≥128 slices or individualised protocols could further improve image quality. The per-patient ROC was 0.97 (95% CI: 0.95-0.98), while the per-segment ROC was 0.99 (95% CI: 0.98-0.99). In addition, prospective-triggered or individualised voltage protocols reduced radiation dose by approximately 50%.

CONCLUSION: Our meta-analysis showed that 370-mgI/ml iopromide contrast-enhanced CCTA delivers consistent image quality and accurate diagnosis of CAD in patients with AF. The use of high-performance scanners combined with individualised protocols and prospective acquisition could further enhance image quality while reducing radiation exposure.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Yang XZ, Hachaichi S, Endrikat J, et al. Protocol and performance of coronary computed tomography angiography in patients with atrial fibrillation: a systematic review and meta-analysis. Clin Radiol. 2025. PMID: 41365092. doi:10.1016/j.crad.2025.107175

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。